Page 8 - Read Online
P. 8

40         Oxidative stress and breast cancer biomarkers: the case of the cytochrome P450 2E1
                            Subir Singh, Ramkumar Rajendran, Kengo Kuroda, Emiko Isogai, Marija Krstic-Demonacos,
                            Constantinos Demonacos
                            J Cancer Metastasis Treat 2016;2:268-276  http://dx.doi.org/10.20517/2394-4722.2016.42


               41         Neuroendocrine tumors: a multidisciplinary approach for a complex disease
                            Rossana Berardi
                            J Cancer Metastasis Treat 2016;2:277-278  http://dx.doi.org/10.20517/2394-4722.2016.50


               42         Neuroendocrine tumors: current therapies, notch signaling, and cancer stem cells
                            Judy S. Crabtree, Lucio Miele
                            J Cancer Metastasis Treat 2016;2:279-293  http://dx.doi.org/10.20517/2394-4722.2016.30

               43         Management of hepatic metastases of well/moderately differentiated neuroendocrine tumors of
                            the digestive tract
                            Anna La Salvia, Stefano Partelli, Marco Tampellini, Domenico Tamburrino, Massimo Falconi, Giorgio
                            V. Scagliotti, Maria Pia Brizzi
                            J Cancer Metastasis Treat  2016;2:294-303  http://dx.doi.org/10.20517/2394-4722.2016.37


               44         Controversies in the treatment of digestive neuroendocrine tumors
                            Maria Rinzivillo, Francesco Panzuto, Gianfranco Delle Fave
                            J Cancer Metastasis Treat 2016;2:304-309  http://dx.doi.org/10.20517/2394-4722.2016.40


               45         Merkel cell carcinoma responsive to Etoposide: a case report and brief literature review
                            Chiara Ancona, Andrea Caff, Giovanni Manfredi Assanto, Stefano Cordio
                            J Cancer Metastasis Treat 2016;2:310-312  http://dx.doi.org/10.20517/2394-4722.2016.46


               46         Review of recent advances in medical treatment for neuroendocrine neoplasms: somatostatin
                            analogs and chemotherapy
                            Francesca Spada, Monica Valente
                            J Cancer Metastasis Treat 2016;2:313-320  http://dx.doi.org/10.20517/2394-4722.2016.38

               47         Double tracer PET/CT: what is it and what does it mean?
                            Mattia Pellicciari, Silvia Ortolani, Elisabetta Grego, Giampaolo Tortora, Sara Cingarlini
                            J Cancer Metastasis Treat 2016;2:321-328  http://dx.doi.org/10.20517/2394-4722.2016.45


               48         Medical therapy for advanced gastro-entero-pancreatic and bronchopulmonary neuroendocrine
                            tumors
                            Mariangela Torniai, Silvia Rinaldi, Francesca Morgese, Giulia Ricci, Azzurra Onofri, Christian Grohé,
                            Rossana Berardi
                            J Cancer Metastasis Treat 2016;2:329-340.  http://dx.doi.org/10.20517/2394-4722.2016.47


               49         Orbital lesions, an exceedingly rare site of neuroendocrine tumor metastasis
                            Sara Pusceddu, Massimo Milione, Silvia Ortolani, Alessio Pellegrinelli, Marco Brugia, Filippo de
                            Braud, Lorenzo Antonuzzo
                            J Cancer Metastasis Treat 2016;2:341-344  http://dx.doi.org/10.20517/2394-4722.2016.41
   3   4   5   6   7   8   9   10   11   12   13